Uswm Ct, Llc
Clinical trials sponsored by Uswm Ct, Llc, explained in plain language.
-
Personalized cell therapy takes on childhood cancers
Disease control Recruiting nowThis study tests a new treatment called afamitresgene autoleucel in children and young adults aged 2 to 21 with advanced cancers that have a specific marker (MAGE-A4). The treatment uses the patient's own immune cells, modified to attack the cancer. The main goals are to check sa…
Phase: PHASE1, PHASE2 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Last-Resort cell therapy opens for sarcoma patients
Disease control AVAILABLEThis program offers a special version of the cell therapy TECELRA® to people with synovial sarcoma or myxoid liposarcoma whose manufactured dose didn't meet commercial standards. It's for patients who have no other practical option to get this treatment. The goal is to provide co…
Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
15-Year safety watch for cell therapy recipients
Knowledge-focused Recruiting nowThis study follows people who have already received ADP adoptive cell therapy for cancer. The goal is to monitor their health for up to 15 years to check for any delayed side effects. About 250 participants will be observed, but no new treatment is given.
Phase: PHASE1 • Sponsor: USWM CT, LLC • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:54 UTC